EUVIMEDEUVIMED entdecken
Crossref

Higher Levels of Immunoglobulin E and Thymus and Activation-Regulated Chemokine Are Associated with Conjunctivitis During Lebrikizumab Treatment in Patients with Moderate-to-Severe Atopic Dermatitis

Teppei Hagino iD, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Dermatitis® · 2025

DOI: 10.1089/derm.2025.0121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatitis®, 2025. Verfasst von Teppei Hagino und 3 weiteren Autor:innen. Beteiligte Einrichtung: From the, Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Immunoglobulin E, Chemokine CCL17, Conjunctivitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicImmunoglobulin EChemokine CCL17ConjunctivitisAntibodies, MonoclonalHumansFemaleMaleProspective StudiesAdultMiddle AgedYoung AdultAdolescentAntibodies, Monoclonal, HumanizedInterleukin-13Severity of Illness Index

Substanzen

Immunoglobulin EChemokine CCL17CCL17 protein, humanAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedInterleukin-13

Autor:innen und Institutionen

  • From the, Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
  • Department of Dermatology, Nippon Medical School, Tokyo, Japan.
  • Fujimoto Dermatology Clinic, Funabashi, Japan.

ORCID-Profile: Teppei Hagino

Zitieren

APA

Hagino, T., Saeki, H., Fujimoto, E., & Kanda, N. (2025). Higher Levels of Immunoglobulin E and Thymus and Activation-Regulated Chemokine Are Associated with Conjunctivitis During Lebrikizumab Treatment in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatitis®. https://doi.org/10.1089/derm.2025.0121

Vancouver

Hagino T, Saeki H, Fujimoto E, Kanda N. Higher Levels of Immunoglobulin E and Thymus and Activation-Regulated Chemokine Are Associated with Conjunctivitis During Lebrikizumab Treatment in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatitis®. 2025. doi:10.1089/derm.2025.0121

BibTeX
@article{Hagino2025,
  author = {Hagino, Teppei and Saeki, Hidehisa and Fujimoto, Eita and Kanda, Naoko},
  title = {Higher Levels of Immunoglobulin E and Thymus and Activation-Regulated Chemokine Are Associated with Conjunctivitis During Lebrikizumab Treatment in Patients with Moderate-to-Severe Atopic Dermatitis},
  journal = {Dermatitis®},
  year = {2025},
  doi = {10.1089/derm.2025.0121}
}
Kostenlos starten →